IGF-1 DES | Buy IGF-1 DES

IGF-1 DES, Buy IGF-1 DES. A shortened peptide form of insulin-like growth factor-1, IGF-1 DES (Des(1-3) IGF-1) is known for its increased potency and targeted anabolic effects, particularly in muscle tissue. It is significantly more accessible than native IGF-1 due to its distinct structure, which enables it to avoid regulatory binding proteins.

• The first three amino acids (Gly-Pro-Glu) at the N-terminus of insulin-like growth factor-1 (IGF-1) are absent in IGF-1DES, a condensed form of IGF-1.
• It is officially known as Des(1-3) IGF-1 and has 67 amino acids.
• Its binding affinity to insulin-like growth factor binding proteins (IGFBPs), which typically control IGF-1 activity, is decreased by this alteration.

IGF-1 DES | Characteristics

• Molecular formula: C319H495N91O96S7
• Molecular weight: ~7371.4 Da
• Due to decreased IGFBP binding, the half-life is extremely brief (minutes).
• Potency: At receptor locations, about ten times more potent than natural IGF-1.
• Bypassing IGFBPs, the mechanism of action involves direct activation of IGF-1 receptors (IGF-1R).

Buy IGF-1 DES | Impacts

• Localized anabolic activity: IGF-1DES stimulates growth and repair in muscle tissue.
• Cellular proliferation: Facilitates muscle hypertrophy by stimulating satellite cell activation.
• Decreased regulation: It can operate directly on tissues because it binds poorly to IGFBPs.
• Potent but short-lived: Because of its quick clearance, its effects are acute and localized rather than systemic.

Positives

• Growth and repair of muscles: Promotes protein synthesis and speeds up recuperation following an injury or strenuous exercise.
• Tissue regeneration is of importance in regenerative medicine because it promotes musculoskeletal tissue recovery.
• Increased bioavailability: IGF-1DES is still active and accessible, in contrast to native IGF-1, which is primarily sequestered by IGFBPs.
• Potential therapeutic usage: Although clinical use is still experimental, research points to potential uses in the treatment of muscle-wasting disorders.

Summary Table